Delivery Order SPE2DB24D1205-SPE2DB24FCSDY

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,663.84, is for the delivery of Orencia Clickject 125 mg/ml medication. It is a firm fixed-price delivery order with an ultimate completion date of October 31, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor and holds an...
This federal contract award, valued at $3,640.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Orencia Clickject 125 mg/ml, a pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,640.93 delivery order contract is for the supply of Orencia Clickject 125 mg/ml, a pharmaceutical product, with a period of performance through April 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Orencia ClickJect 125 mg/mL medication. The $22,064.68 firm fixed price delivery order contract has an ultimate completion date of August 5, 2024. The contract is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies...
This contract award, valued at $13,154.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orencia Clickject 125 mg/ml medication. It is a firm fixed-price delivery order contract with an ultimate completion date of April 9, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Orencia Clickject 125 mg/ml to the Defense Logistics Agency (DLA), a defense agency. The $3,594.04 firm-fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 12, 2025 with a completion date of June 13, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orencia ClickJect 125 mg/ml medication. The award has a total ceiling value of $3,594.04 and is structured as a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $40,970.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA CLICKJECT 125 MG/MLML, a medical product, with a completion date of March 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,663.84 firm fixed-price contract is for the delivery of Orencia ClickJect 125 mg/mL medication, with a performance period through July 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,572.03 firm fixed-price delivery order is for the supply of Orencia ClickJect 125 mg/mL, a specialty medication. The contract has an ultimate completion date of January 31, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCSDY
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Orencia Clickject 125 mg/ml medication. The contract, valued at $42,402.29, was awarded by the Defense Logistics Agency (DLA) and has a completion date of June 21, 2024. The contract is a Firm Fixed Price Delivery Order, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:55 AM